| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.63M | -10,000 | |
| VP | 83.7K | $16.19M | - | |
| VP | 38.3K | $7.42M | - | |
| VP | 34.5K | $6.67M | - | |
| CFO | 33.4K | $6.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2017 | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 7,162 | $98.28 | $703,907.62 | -4.4% | |
| Mar 1, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 470 | $97.77 | $45,951.90 | -1.2% | |
| Feb 27, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 440 | $97.39 | $42,851.60 | -1.1% | |
| Feb 22, 2017 | Ziegler John B | Director | Sell | 2,000 | $95.51 | $191,016.00 | -10.8% | |
| Feb 15, 2017 | Doherty Catherine T.55 | SVP, Clin. Franchise Solutions | Sell | 1,615 | $94.65 | $152,858.14 | -2.2% | |
| Feb 13, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 1,200 | $93.76 | $112,512.00 | -2.9% | |
| Feb 2, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 45,000 | $92.39 | $4,157,595.00 | -34.9% | |
| Jan 30, 2017 | Doherty Catherine T.55 | SVP, Clin. Franchise Solutions | Sale+OE | 80,000 | $90.58 | $7,246,362.28 | -24.9% | |
| Nov 15, 2016 | Pfeiffer Gary M | Director | Sale+OE | 42,643 | $85.09 | $3,628,425.15 | -25.6% | |
| Aug 19, 2016 | Britell Jenne K | Director | Sale+OE | 4,000 | $84.76 | $339,052.00 | -16.7% |